|Anti-hTNF-α-hIgA2||Unit size||Cat. code||Docs||Qty||Price|
Human TNF-α (adalimumab) antibody - Human IgA2
Neutralizing human IgA2 monoclonal antibody against human TNF-α
Anti-hTNF-α-hIgA2 is a neutralizing monoclonal antibody featuring the constant region of the human IgA2 isotype and the variable region of adalimumab.
Adalimumab is a fully human monoclonal antibody against the pro-inflammatory cytokine human tumor necrosis factor alpha (hTNF-α).
Adalimumab binds to TNF-α and blocks its interaction with TNF receptors thereby downregulating the inflammatory reactions associated with autoimmune diseases, such as rheumatoid arthritis and Crohn’s disease.
Anti-hTNF-α-hIgA2 was generated by recombinant DNA technology. It has been produced in CHO cells and purified by affinity chromatography with peptide M.
The neutralizing activity of this human IgA2 antibody was determined using HEK-Blue™ TNF-α/IL-1β cells.Back to the top
Clonality: Monoclonal antibody
Application: Neutralization of human TNF-α-induced cellular activation
Specificity: Human TNF-α
Isotype: Human IgA2Back to the top
- 100 µg purified anti-hTNFα-hIgA2 antibody, provided azide-free and lyophilized
Product is shipped at room temperature.
Store lyophilized antibody at -20°C.
Lyophilized product is stable for 1 year when properly stored.Back to the top